Aflac Incorporated
AFL Financial Services Insurance - Life NYSE
$111.29
+$0.25 (+0.23%)
Open: $110.29 | High: $111.48 | Low: $108.98 | Prev Close: $111.04
Market Cap: $57.47B
Volume: 1.6M | Avg: 2.4M
Last updated: March 09, 2026 at 02:00 AMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 490
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 16.32 |
| P/B Ratio | 2.00 |
| P/S Ratio | 3.31 |
| EPS | $6.82 |
| Beta | 0.65 |
| Shares Outstanding | 516.37M |
| 52-Week High | $119.32 |
| 52-Week Low | $96.95 |
| SMA 50 | $111.65 |
| SMA 200 | $107.91 |
| Dividend Yield | 2.11% |
| Annual Dividend | $2.35 |
| Next Earnings | April 29, 2026 08:00 PM ET |
Financial Ratios
| Gross Margin | 38.7% |
| Operating Margin | 26.3% |
| Net Margin | 21.0% |
| ROE | 13.1% |
| ROA | 3.1% |
| Debt/Equity | 0.29 |
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
Balance Sheet
| Total Assets | $116.47B |
| Total Liabilities | $86.98B |
| Total Equity | $29.49B |
|
|
|
| Cash | $6.25B |
| Total Debt | $8.41B |
| Net Debt | $2.16B |
Income Statement
| Revenue | $17.44B |
| Gross Profit | $6.79B |
| Operating Income | $4.64B |
| Net Income | $3.65B |
|
|
|
| EBITDA | $5.53B |
| Revenue/Share | $32.75 |
Cash Flow
| Operating CF | $2.56B |
| CapEx | N/A |
| Free Cash Flow | $2.56B |
|
|
|
| Book Value/Share | $55.64 |
| Tangible Book/Share | $38.59 |
| Equity/Share | $55.64 |
Technical Indicators
| RSI (14) | 27.55 Oversold |
| MACD |
-0.29
Signal: 0.24
|
| Volatility | 20.15% |
| Trading Signal | Oversold |
Performance & Returns
| 1 Year | +4.57% |
| Sharpe Ratio | 0.1 Fair |
| Volatility (Ann.) | 16.98% Low Risk |
| AFL (1Y) | +4.57% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | -8.47% |
Sector Comparison (Financial Services)
| Metric | AFL | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 16.32 | 47.88 | 33% |
| P/B Ratio | 2.0 | 4.21 | 46% |
| ROE (%) | 13.05% | 19.82% | 42% |
| Net Margin (%) | 21.00% | 18.71% | 69% |
| Stock Score | 490 | 429.0 | 64% |
| 1Y Return (%) | +4.57 % | +8.00 % | 40% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFL | $111.29 | $111.27 | $111.80 | $112.23 | $111.56 | $107.89 | 27.55 | -0.29 | 20.15% | 380638 | Strong Short | Bearish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the AFL stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| AFL | Aflac (NYSE:AFL) Major Shareholder Post Holdings Co. Ltd. Japan Sells 19,300 Shares | Neutral | defenseworld.net | Read More |
| AFL | Aflac Incorporated $AFL Shares Sold by Barclays PLC | Neutral | defenseworld.net | Read More |
| AFL | Aflac (AFL) Down 5.5% Since Last Earnings Report: Can It Rebound? | Neutral | zacks.com | Read More |
| AFL | Elo Mutual Pension Insurance Co Increases Position in Aflac Incorporated $AFL | Positive | defenseworld.net | Read More |
| AFL | Best Dividend Aristocrats For March 2026 | Neutral | seekingalpha.com | Read More |
Recent Insider Trading
No recent insider trading data available for AFL
Company Information
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
| CEO | Daniel Paul Amos |
| Employees | 12694 |
| Country | US |
| IPO Date | 1980-03-17 |
| Exchange | NYSE |
| Website | https://www.aflac.com |
| Sector | Financial Services |
| Industry | Insurance - Life |
Similar Stocks (Financial Services - Insurance - Life)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category